| Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the clinical sequencing exploratory research consortium LM Amendola, GP Jarvik, MC Leo, HM McLaughlin, Y Akkari, MD Amaral, ... The American Journal of Human Genetics 98 (6), 1067-1076, 2016 | 599 | 2016 |
| ACMG SF v3. 0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG) DT Miller, K Lee, WK Chung, AS Gordon, GE Herman, TE Klein, ... Genetics in medicine 23 (8), 1381-1390, 2021 | 442 | 2021 |
| Return of genomic results to research participants: the floor, the ceiling, and the choices in between GP Jarvik, LM Amendola, JS Berg, K Brothers, EW Clayton, W Chung, ... The American Journal of Human Genetics 94 (6), 818-826, 2014 | 423 | 2014 |
| Actionable, pathogenic incidental findings in 1,000 participants’ exomes MO Dorschner, LM Amendola, EH Turner, PD Robertson, BH Shirts, ... The American Journal of Human Genetics 93 (4), 631-640, 2013 | 415 | 2013 |
| Actionable exomic incidental findings in 6503 participants: challenges of variant classification LM Amendola, MO Dorschner, PD Robertson, JS Salama, R Hart, ... Genome research 25 (3), 305-315, 2015 | 369 | 2015 |
| Variation among DNA banking consent forms: points for clinicians to bank on SJ Huang, LM Amendola, DL Sternen Journal of community genetics 13 (4), 389-397, 2022 | 343 | 2022 |
| Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and … DT Miller, K Lee, AS Gordon, LM Amendola, K Adelman, SJ Bale, ... Genetics in Medicine 23 (8), 1391-1398, 2021 | 182 | 2021 |
| Clinical sequencing exploratory research consortium: accelerating evidence-based practice of genomic medicine RC Green, KAB Goddard, GP Jarvik, LM Amendola, PS Appelbaum, ... The American Journal of Human Genetics 98 (6), 1051-1066, 2016 | 169 | 2016 |
| Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study MR Hart, BB Biesecker, CL Blout, KD Christensen, LM Amendola, ... Genetics in Medicine 21 (5), 1100-1110, 2019 | 147 | 2019 |
| Next-generation sequencing panels for the diagnosis of colorectal cancer and polyposis syndromes: a cost-effectiveness analysis CJ Gallego, BH Shirts, CS Bennette, G Guzauskas, LM Amendola, ... Journal of Clinical Oncology 33 (18), 2084, 2015 | 146 | 2015 |
| ACMG SF v3. 1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG) DT Miller, K Lee, NS Abul-Husn, LM Amendola, K Brothers, WK Chung, ... Genetics in Medicine 24 (7), 1407-1414, 2022 | 142 | 2022 |
| The clinical sequencing evidence-generating research consortium: integrating genomic sequencing in diverse and medically underserved populations LM Amendola, JS Berg, CR Horowitz, F Angelo, JT Bensen, BB Biesecker, ... The American Journal of Human Genetics 103 (3), 319-327, 2018 | 137 | 2018 |
| ADCY5-related dyskinesia: Broader spectrum and genotype–phenotype correlations DH Chen, A Méneret, JR Friedman, O Korvatska, A Gad, ES Bonkowski, ... Neurology 85 (23), 2026-2035, 2015 | 122 | 2015 |
| Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium JS Berg, LM Amendola, C Eng, E Van Allen, SW Gray, N Wagle, HL Rehm, ... Genetics in Medicine 15 (11), 860-867, 2013 | 101 | 2013 |
| Return of incidental findings in genomic medicine: measuring what patients value—development of an instrument to measure preferences for information from next-generation … CS Bennette, SB Trinidad, SM Fullerton, D Patrick, L Amendola, W Burke, ... Genetics in Medicine 15 (11), 873-881, 2013 | 88 | 2013 |
| Frequency of genomic secondary findings among 21,915 eMERGE network participants AS Gordon, H Zouk, E Venner, CM Eng, BH Funke, LM Amendola, ... Genetics in Medicine 22 (9), 1470-1477, 2020 | 76 | 2020 |
| A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories JM O’Daniel, HM McLaughlin, LM Amendola, SJ Bale, JS Berg, D Bick, ... Genetics in Medicine 19 (5), 575-582, 2017 | 71 | 2017 |
| A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record P Tarczy-Hornoch, L Amendola, SJ Aronson, L Garraway, S Gray, ... Genetics in Medicine 15 (10), 824-832, 2013 | 69 | 2013 |
| Clinical providers’ experiences with returning results from genomic sequencing: an interview study J Wynn, K Lewis, LM Amendola, BA Bernhardt, S Biswas, M Joshi, ... BMC medical genomics 11, 1-13, 2018 | 65 | 2018 |
| ACMG SF v3. 2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG) DT Miller, K Lee, NS Abul-Husn, LM Amendola, K Brothers, WK Chung, ... Genetics in Medicine 25 (8), 100866, 2023 | 53 | 2023 |
